Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Phase 1 Completed
18 enrolled
TraveraRTGx
Completed
72 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
215 enrolled 30 charts
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
Phase 2 Completed
99 enrolled
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
Phase 1 Completed
53 enrolled
EARN
Phase NA Completed
33 enrolled
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
DELFI-L101
Completed
2,992 enrolled
CNSI-Fe(II)
Phase 1 Completed
19 enrolled 47 charts
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Completed
7 enrolled
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Phase 1 Completed
185 enrolled 28 charts
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Phase 1 Completed
56 enrolled 19 charts
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.
Phase 2 Completed
40 enrolled
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
Phase 1 Completed
46 enrolled
Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers
Phase NA Completed
87 enrolled
A Study of CDX-585 in Patients With Advanced Malignancies
Phase 1 Completed
20 enrolled
PROACC-1
Phase 2 Completed
187 enrolled 24 charts
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
PREVAILctDNA
Completed
128 enrolled
Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
Phase 1 Completed
86 enrolled
Study of XB002 in Subjects With Solid Tumors (JEWEL-101)
Phase 1 Completed
269 enrolled
PREFER
Completed
1,429 enrolled
IT-01
Phase 1/2 Completed
111 enrolled 21 charts
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.
Phase NA Completed
40 enrolled
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Phase 1 Completed
37 enrolled
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Phase 3 Completed
405 enrolled 11 charts
8479217
Phase 1 Completed
6 enrolled 17 charts
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Phase NA Completed
128 enrolled 24 charts
REMOVE
Phase NA Completed
136 enrolled
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
Phase 1/2 Completed
79 enrolled
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
ROOT
Completed
167 enrolled
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Phase 1 Completed
12 enrolled
A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)
Phase 1 Completed
95 enrolled
IVY
Phase 1 Completed
353 enrolled
SPIRIT
Phase 2 Completed
121 enrolled 12 charts
A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer
Phase 1 Completed
49 enrolled
DUET-3
Phase 1 Completed
198 enrolled
Study of SRF617 in Patients With Advanced Solid Tumors
Phase 1 Completed
85 enrolled
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Phase NA Completed
38 enrolled
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies
Phase 2 Completed
61 enrolled 24 charts
Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Phase 2 Completed
730 enrolled 25 charts
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
Phase 1 Completed
41 enrolled
A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer
Phase 1 Completed
52 enrolled 21 charts
Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
Phase 1 Completed
27 enrolled 24 charts